Trial Profile
An International, Observational Study to Define Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Acronyms INTEREST IN CD1
- Sponsors Ipsen
- 16 Sep 2020 Results of metaanalysis of three observational studies (INTEREST IN CD1, INTEREST IN CD2 and ANCHOR CD) evaluating the effect of abobotulinumtoxinA on pain associated with cervical dystonia presented at the 24th International Congress of Parkinson's Disease and Movement Disorders
- 22 May 2019 Results assessing economic evaluation of abobotulinumtoxinA vs onabotulinumtoxinA by using data from this study presented at the 24th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.
- 28 Nov 2018 New trial record